Announcements Trials
Browse Landscape

Phase

Phase 3 19Phase 2 19Phase NA 17Phase 4 14Phase 1/2 5Phase 2/3 2Phase 1 2

Status

Completed 74Terminated 15Recruiting 7Unknown 2Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 249Gastrointestinal 246Lymphoid 190Other hematologic neoplasm 148Thoracic 130Breast 100Genitourinary 84Gynecologic 82Dermatologic 70Tumor-Agnostic 69Plasma cell 63CNS 61Head & Neck 54Sarcoma 33Myeloid 22Endocrine 12Other neoplasm 7NET 5Classical hematology 2

Conditions

Myelodysplastic Syndromes 2Primary Immunodeficiency Diseases 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Graft vs Host Disease 1Anemia, Refractory, with Excess of Blasts 1Anemia, Aplastic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Classical hematology × Clear all
NCT04429191 2021-06-11

JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Jasper Therapeutics, Inc.

Phase 1 Unknown
40 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03836690 2019-10-25

ToTem

University College, London

Phase 1 Unknown
18 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Primary Immunodeficiency Diseases, Anemia, Aplastic, Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡